Exelixis (EXEL) 10-Q2016 Q1 Quarterly report

Filed: 4 May 16, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abroad, aimed, Analyzing, ANVISA, asserting, atezolizumab, Australia, begun, Brazil, bulk, burden, CABOMETYX, CABOMETYXTM, contrary, court, deliverable, dispute, effort, endometrial, entertainment, entirety, excise, fact, flat, formal, France, Germany, hand, hiring, iii, importantly, IND, inter, internationally, Ipsen, Italy, Japan, judgment, kidney, Kingdom, minimize, nonrefundable, NPU, opposition, ORR, overcome, packaged, people, Pharma, placebo, predominant, proceeding, recall, recoverability, reexamination, repaid, requisite, resolve, resolved, robust, role, SAS, science, simplification, sizable, Spain, speed, steering, subgroup, Symposium, thirty, Trademark, travel, triple, undelivered, unenforceable, unsold, vemuarfenib

Removed: acceleration, adult, affiliated, annually, applied, apportioned, Audit, automatic, biologic, Brain, branded, breakdown, Budget, Carlo, chain, comparative, comparator, conditional, conference, Congressional, contaminated, continuation, core, correctly, correspondingly, counterfeit, created, creation, CRPC, cumulative, deducting, deduction, deposited, designation, detection, discontinued, dispensed, distributer, distributor, divided, domestic, eligibility, Engineered, enhanced, enrolled, escrow, exercisable, exercising, expiry, exploit, family, financed, forecast, fourth, goal, grouped, growth, half, headcount, hierarchy, historically, impacting, inclusive, initially, investigative, IV, kinase, lender, licensed, Lymph, Master, minimum, molecule, Monte, negotiate, Neoadjuvant, Node, nondeductible, noted, Obama, occupying, Open, operation, organizational, originally, oversee, Overview, Palpable, phased, Poverty, predominantly, presently, preservation, President, priority, promised, promotional, prompt, rational, rebate, reclassified, recognizing, recommend, reduced, relevance, relief, removed, renegotiate, REPOSIT, repricing, retrospectively, revaluation, Select, selection, shift, similarly, Simplifying, simulation, spending, staged, statute, stolen, structure, sustain, tactical, Taxpayer, teaching, tolerated, Topic, tracing, transitional, transitioned, trillion, undertaken, verification, vest, workforce, Zelboraf

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

EXEL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and Section 1350 of Chapter 63 of Title 18 of the United States Code, Michael M. Morrissey, Ph.D., the President and Chief Executive Officer of Exelixis, Inc. (the “Company”), and Christopher J. Senner, the Executive Vice President and Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

1. The Company’s Quarterly Report on Form 10-Q for the period ended April 1, 2016, to which this Certification is attached as Exhibit 32.1 (the “Quarterly Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

In Witness Whereof, the undersigned have set their hands hereto as of the 4th day of May 2016.



/s/ MICHAEL M. MORRISSEY				/s/ CHRISTOPHER J. SENNER
Michael M. Morrissey, Ph.D.				Christopher J. Senner
President and Chief Executive Officer (Principal Executive Officer)				Executive Vice President and Chief Financial Officer (Principal Financial Officer)